Hansoh Pharma IPO: Valuation Reasonable for the Trade-Offs
Hansoh Pharmaceutical (3692 HK) claims to be one of the few R&D driven Chinese pharmaceutical companies. It announced its IPO price range of...
830 Views
ECM Weekly (1 Jun 2019) - Hansoh, China East Edu, GSX, CSSC (HK) Shipping, China Tobacco
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
839 Views
Hansoh Pharma (翰森制药) IPO: Strong Cornerstone Line-Up, Upside at Low End
Hansoh Pharma, the largest pharmaceutical listing in Hong Kong this year, launched its book building today. In our previous insights (links...
985 Views
Hansoh Pharma (翰森制药) IPO: Inebilizumab License-In from Viela Bio a Symbolic Deal
Just ahead of the launch of Hansoh Pharma's book building for its USD 1bn IPO, news reported today that Hansoh inked a license-in agreement with...
948 Views
ECM Weekly (25 May 2019) - ESR Cayman, Hansoh Pharma, Tai Hing, China East Edu, Haitong UniTrust
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
847 Views